speb/financial-data huggingface dataset:
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 39546000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 39546000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 131054762.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.42
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 55043000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — EBIT: 115675000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — EBITDA: 155221000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 31634000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 6301268000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 487458000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 40612000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 40612000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 1087171000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 8741539000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 64643000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 31219000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1196886000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1228105000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 4575000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 1717345000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income: 55043000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 55043000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 55043000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 55043000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 55043000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 55043000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -40612000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -40612000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 6301268000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 6865224000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 186445000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 155221000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 55043000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Income: 111038000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 1400972000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 129669080.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 567886000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 28899000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 6767189000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 31634000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 77935000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 4636000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 221310000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 2527632000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 16235000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 1047610000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 75063000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 913514000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 39546000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 129669080.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6896858000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 6865224000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 20020000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.27
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 1449000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 10394955000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 8093744000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1888293000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 6896858000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 1289934000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 3498097000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 6475480000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1425224000.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1900000.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
BHAGCHEM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 1846602000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 401756000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 1139718000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 128216667.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.36
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 649988000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 48757000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 48757000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 128216667.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.36
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 46158000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — EBIT: 93856000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 142613000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 489730000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 30965000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 30965000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income: 46158000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 46158000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 46158000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 46158000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 46158000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 46158000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -30965000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -30965000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 142613000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 46158000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Income: 87974000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 1139718000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 5882000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 234365000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 62891000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 649988000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 48757000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 16733000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.27
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 1051744000.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
BHAGCHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 900310000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 503339000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 5358580000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 1580965000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1380914000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1380914000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2046824000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2046824000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -1184980000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1184980000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 4739728000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 4739728000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -258000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -258000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Amortization: 6075000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 66345000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 66345000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 129669080.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 131419355.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Basic EPS: 1.40
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 0.31
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 282253000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 1565735000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 1565735000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1601386000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 35861000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 35861000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 129669000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 129669000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 157407000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 157407000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 157407000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 157407000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -19492000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 157407000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 157407000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -160436000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -256504000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -14095000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Change In Payable: 443527000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -306599000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -294107000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -118781000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 129669000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 129669000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 6983228000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6983228000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 0.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 956357000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 956357000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 4094618000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 965807000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 4364881000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 4364881000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 12326000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 12326000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 779177000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 779177000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 791503000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 791503000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Current Deferred Taxes Liabilities: 0.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Deferred Taxes Liabilities: 0.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 2455429000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2455429000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation: 209331000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 209331000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 209331000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 82369000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 203256000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 82369000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 129669080.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 131419355.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Diluted EPS: 1.40
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.31
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 181732000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 40740000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Dividends Payable: 141000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Dividends Payable: 141000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — EBIT: 341889000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — EBIT: 118555000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — EBITDA: 551220000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — EBITDA: 200924000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 43000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 163515000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 1362804000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Finished Goods: 502557000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Finished Goods: 502557000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -1481250000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 487000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 78420000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 28521000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 28521000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 2047082000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 2047082000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 7925016000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 7925016000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Gross Profit: 1263962000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 615158000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Hedging Assets Current: 3675000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 3675000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Interest Expense: 130818000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 70451000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 130818000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 70451000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Interest Income: 9872000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 9872000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -71796000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 9577000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Inventory: 1457545000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1457545000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 9293757000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 9293757000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -1601721000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 66345000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 66345000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 0.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 159273000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 159273000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 23535000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 23535000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 1531352000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1531352000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1554887000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1554887000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 4657918000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 4657918000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 0.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 2153122000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 2153122000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 3945000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Net Income: 181732000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income: 40740000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 181732000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 40740000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 181732000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 40741000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 181732000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 40740000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 181732000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 40740000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 211071000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 181732000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 40741000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -143334000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -70451000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -11088000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 1466412000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 1231255000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -143334000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -70451000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -1000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 6740036000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 6740036000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1600209000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 235157000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 6954707000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 6954707000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Revenue: 6099000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Revenue: 6099000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 193927000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 193927000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 8353000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 8353000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Prepaid Assets: 52962000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 52962000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 551220000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 200924000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Normalized Income: 181732000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 40740000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 120136000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Operating Income: 363652000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Income: 111819000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 5358580000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1580965000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 129669080.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 129669080.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: -1000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: -1000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: -2000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: -2000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 6853560000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 6853560000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 28521000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 28521000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Inventories: 3775000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Inventories: 3775000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 65713000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: -2000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: -2000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 1000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 12182000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 6734000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 17890000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 274487000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Payable: 253653000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 253653000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 585733000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 585733000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 2916000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 2916000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 33181000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 33181000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Payables: 1634708000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 1634708000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 29220000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 29220000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 657099000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 657099000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Pretax Income: 211071000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 48104000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Properties: 0.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1601386000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Raw Materials: 593861000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Raw Materials: 593861000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 4094618000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 965807000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 209331000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 82369000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 1084000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 1084000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Research And Development: 31316000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Restricted Cash: 31818000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 31818000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 2029509000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 2029509000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 1177000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 70011000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 148431000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 129669080.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 129669080.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 6983228000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 6983228000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 6954707000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 6954707000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Tax Provision: 29339000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 7363000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.14
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.15
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 7598000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 7598000.00
BHAGCHEM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -76303000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 11201924000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 11201924000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 8514580000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 8514580000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 2346390000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 2346390000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 6983228000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 6983228000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Total Expenses: 4994928000.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1469146000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 4218696000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4218696000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 6837043000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 6837043000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1763267000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1763267000.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Total Other Finance Cost: 22388000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 0.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 0.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
BHAGCHEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BHAGCHEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Work In Process: 357352000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Work In Process: 357352000.00
BHAGCHEM.NS balance_sheet (annual, 2026-03-31) — Working Capital: 1909452000.00
BHAGCHEM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1909452000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -1419639000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 51000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 501499000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 140261000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 81275000.00
BHAGERIA.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 0.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 24000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 7768000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 178000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 186169000.00
BHAGERIA.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 23429000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Goodwill: 134000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 1039448000.00
BHAGERIA.NS income_statement (annual, 2022-03-31) — Interest Income: 26380000.00
BHAGERIA.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 26380000.00
BHAGERIA.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 0.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1133463000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 3482800000.00
BHAGERIA.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
BHAGERIA.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -1000.00
BHAGERIA.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: 33546000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Revenue: 58545000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 21693000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 25181000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 134000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 5040000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Other Payable: 168000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 7014000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 52816000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 404315000.00
BHAGERIA.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 7588000.00
BHAGERIA.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 7588000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 113242000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 3401078000.00
BHAGERIA.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 141331000.00
BHAGERIA.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 164760000.00
BHAGERIA.NS income_statement (annual, 2022-03-31) — Special Income Charges: 0.00
BHAGERIA.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 3240000.00
BHAGERIA.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 29007000.00
BHAGERIA.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 29007000.00
BHAGERIA.NS balance_sheet (annual, 2022-03-31) — Work In Process: 57779000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1188290000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — +Total Revenue: 4992199000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 399189000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1274960000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1762059000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 51000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 177452000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 43644180.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Basic EPS: 3.38
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 221537000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 501499000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -137038000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 218221000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 110686000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 431123000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -174705000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 56852000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 53834000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 222354000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -32736000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -40881000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Change In Payable: -116287000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -235513000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -204644000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -110851000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Common Stock: 218221000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 5061300000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 2401000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 84756000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 3600528000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Current Assets: 2372217000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Current Debt: 367815000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 367815000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 8368000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 837427000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 8677000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Depreciation: 344349000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 344349000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 344349000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 344349000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 43644180.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Diluted EPS: 3.38
BHAGERIA.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 147454000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 7896000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 632000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — EBIT: 233862000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — EBITDA: 578211000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — End Cash Position: 110686000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 146000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -155945000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 109019000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 139097000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -1582000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -87000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 23489000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Goodwill: 134000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 134000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1274960000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 5475741000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Gross Profit: 1391671000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Interest Expense: 30182000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 30182000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Interest Income: 27409000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 27409000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -37063000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 26451000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Inventory: 430947000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 5441987000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -231041000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 22881000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 177598000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 2401000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 53421000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 1140181000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 12872000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 12872000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 53421000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 23205000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 3525795000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 2130000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Minority Interests: 352000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 2401000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Net Debt: 270001000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Net Income: 147454000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 147454000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 147103000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 147454000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 147454000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 203680000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 147102000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Net Interest Income: -4363000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -121690000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 53421000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 53421000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -4363000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 1000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -1000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Net PPE: 3713682000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -136433000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 23421000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 5061166000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 57096000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 319840000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 23205000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 27362000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 575450000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Normalized Income: 145459933.90
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 276135000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Operating Income: 203381000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Operating Revenue: 4992199000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 43644180.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 3000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 1822000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 17371000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 134000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 4540000.00
BHAGERIA.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 6214000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -3000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 1000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 7629000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 415454000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Other Payable: 1532000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Other Properties: 223510000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 26842000.00
BHAGERIA.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 320437000.00
BHAGERIA.NS income_statement (annual, 2023-03-31) — Other Special Charges: -1811000.00